Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
At 24 Million market cap it is extremely overvalued. About 3 1/2 qtrs of cash on hand to do nothing but the status quo of paying crooks and 2.5 Billion shares outstanding this POS still has a long way to fall.
Will Kenny cut his salary until IND is approved? LOL This was all part of the plan Kenny delivers his "promise" of IND knowing that no way FDA approves it (after all it was free to submit) and now Shady Boy can milk another couple years of Million $$ salary and explain to shareholders its so complicated.
How many years will it take for PMCB to respond? Kenny will let you know that it will take as long as it takes so that it is perfect because we only have one shot at this. Oh wait two shots? Well as many as it takes until Kenny wants to retire.
All is good. Kenny gets paid full salary for filing the IND so .. The only people that win in the end are those who are not Investors in PMCB and that would be every person that works or consults for them as they have never invested a penny of their own money in this SCAM.
"Complicated" LOL Kenny speak for a lawyer pretending to run a Biotech. For any real Biotech this tech would be considered primitive. Its a cell line encapsulated in cotton. Whooo so complicated.
As of a week ago already 5 interactions with the FDA and who knows how many since. Then a Hold is placed on IND so I am sure given the rapid progress PMCB makes (Only 8 years to file an IND for a treatment that was already in trials) it should only take Kenny 10-15 years to iron things out. "We only have one shot to get this right"
We only have one chance to get this right. Or two or a hundred or until there is no more money to pay Shady Kenny. On Hold Shocking. Sub-Penny Shocking. LOL Maybe some will learn this has never been about anything but making Kenny and Pals lots of cash.
LOL .50 that would put PMCB market cap at 1.2 Billion. LMFAO. Keep the dream alive because that's all it is.
Problem is with 2.5 Billion shares trading a couple of million is not reflecting real value. Pausing the selling to allow price to recover before resuming the selling is all this is.
Most importantly even in a reality where CIAB actually does what it did in the Lohr 20 year old trial the only outcome would be some patients might live a few weeks longer. CIAB will cure nothing. And in the real reality CIAB being used as a 2nd line treatment has never been studied in any patients so the Lohr trials contain no useful data at all.
Not surprising that the Kenny Maniacs think having the FDA ask on five different occasions for information is a good thing. And Kenny knowing his audience feeds them. And comparing a GMP audit to an IND filing is foolish.
CIAB is suppose to avoid that by placing the drug right at the point of the cancer.
So lets pretend the FDA approves the IND and that someone is going to fund the trial. (LMAO) what do you think this entity would get in return for funding a $15 Million dollar trial? Does anyone who believes this really think shareholders would reap the rewards? Whether PMCB is a SCAM or someone funds a successful trial you can bet shareholders will get NOTHING because Kenny is the keeper of the Magic Share. Now reality. No one is giving Shady Kenny $15 Million to run a clinical trial. No one even buys a share stock from this company holds it for a day longer then they have to.
High probability of outside funding availability if IND approved. LOL High probability lol lol
And what percentage is that spread? Nothing unusual at all actually a much larger percentage then most.
Oh I forgot you actually need to click on the link and read.
Dr. Manuel Hidalgo.
ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment
https://markets.businessinsider.com/news/stocks/erytech-announces-the-hosting-of-a-kol-event-as-the-trybeca-1-phase-3-trial-in-second-line-pancreatic-cancer-nears-complete-enrollment-1029587585
(((( EPIC FAILURE !!!!! )))) Ya that sums it up. PMCB is an (((( EPIC FAILURE !!!!! ))))
You know why a company would trade in OTC land for all its 20+ years existence? Because that's where all SCAMS trade in penny land where dreams of riches are just that dreams. PMCB is a SCAM and always has been.
Thinking about how to spend the Millions made when PMCB is bought out by some Mega Pharma meanwhile Mr. Reality has been kicking the snot out of PMCB.
Another week of losses and another week of making pretend PMCB is going to be bought out for Billions. FYI the PPS is a penny. PMCB has 2.5 Billion shares and only three months of "status quo" cash on hand. PMCB has a 20 year old technology unwanted by anyone that has no patent protection. PMCB is run by a 72 year old Penny Stock Lawyer and his pal who are both from a previous scam called Chinatel. PMCB employees no Medical or Regulatory personnel. They have no physical location. They spend almost nothing on R&D and almost everything on paying Kenny and Carlos. PMCB has been "promoting" clinical trials for 9 years yet has not produced any clinical or pre-clinical data on anything. PMCB is a Stock Selling Scam that has so many Red Flags they should be called Red Flag Biotech. IMHO
Cash on hand will be less then 3 million at the end of this qtr. In typical Kenny fashion the numbers are made to look better then they are. 4.5 million on hand 8/31/20 300k a month in normal expense brings it to 3.9 million end of qtr. Then the 1.2 million in current liabilities brings it to 2.7 million beginning of Nov. So with just the avg 900k spend per qtr doing nothing they will have 3 qtr's of cash left with 2.5 Billion shares already.
Don't forget this Beauty of a PT from the time machine. This is how long PMCB has been PUMPING CIAB.
Nuvilex Sets Stage to Finalize Agreements with Major Pharmaceutical Companies
October 06, 2011 11:26 AM Eastern Daylight Time
SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX) announced SG Austria has appointed Dr. Stephen Rhind as a consultant to lead its business development activities and finalize pending contracts with major pharmaceutical companies that are currently in their pipeline. Dr. Rhind was selected for having a 28-year track record of achievement in negotiating multimillion dollar contracts with major biotechnology and pharmaceutical companies including GSK (GSK), Onyx Pharmaceuticals, Inc. (ONXX) and Enzon Pharmaceuticals, Inc. (ENZN).
Nuvilex President and CEO Dr. Robert F. Ryan stated, "We are extremely pleased that Dr. Rhind has joined us. This will enable SG Austria to conclude contracts it currently has in its pipeline with major pharmaceutical companies, enhancing our ability to more rapidly convert our technology and value into revenue. Dr. Rhind’s major areas of focus initially will be to assist Nuvilex and SG Austria into further expanding use of their encapsulation technology and advancement of our pancreatic and other developing cancer treatments."
As a company working as rapidly as possible to help develop treatments for people with pancreatic cancer, Nuvilex wants to express our deepest condolences to Steve Jobs’ family.
LOL 1.1 pennies. No interest from any real investors ever including insiders. No insider has ever purchased a share of stock with their own money and every insider that has left dumped their shares before the door hit them on the way out. Existing shareholders spend their money averaging down every week because the stock never goes up unless a fairy tale paid for article tricks is released and then only for a day. One BILLION shares sold at sub-penny in the last few months and buyer couldn't wait to dump those ASAP. PMCB/Nuvilex/Efood safety three names same SCAM. How deep is the ocean? PMCB keeps sinking to new depths every week. Kenny does that all for his $Millions in unearned pay though.
See what I mean what real investor would care about what a penny stock investor thinks.
His reputation to who? A couple hundred penny stock investors who think SMMG is a news site. LOL Its not like any real investors know he consults for PMCB nor would they care. Everyone in the Biotech world knows these Dr's make money on the side from consulting. Von Hoff consults for 8-10 Biotech's at the same time. Its is LOL Silly that anyone thinks Hidalgo's reputation has anything to do with PMCB.
Or already rejected. Just be ready... LOL
Ya the "Trade Secrets" statement is hilarious and BTW go to a real Biotech's website and read the presentations they give there is a hundred thousand more "Secrets" then PMCB would have if they released every bit of data on CIAB created over the past 20+ years. Trade Secrets LOL LOL.
No instead he buried it in subsequent events. You won't know the FDA rejected the IND until the next 10q in Dec.
The FDA may have rejected IND already. Just be ready.
LOL .0101 Ya 2 one hundredths of a penny is something to cheer about. What a POS company and CEO.
Once the seller runs out of shares there will be more shares sold. Also the buyers of these shares are not in it like the dreamers most will flip at any rise in price for a quick profit. When you have 2.5 Billion shares and soon will need to issue more the selling will never stop.
Its obvious they Billion shares dump by Kenny before Ind was to raise maximum amount of cash before FDA rejection. Even Kenny isn't dumb enough to sell a Billion shares at the absolute lowest price ever. The cash on hand is for payroll not trials. Oh ya the Magic Funding Fairy is going to pay for the trials so shareholders can become rich. LMAO
YAWN. And here PMCB sits at 1.1 pennies and red every day. Truth is anyone with an ounce of common sense knows PMCB's "treatment" is worthless. Kenny and pals are the only ones walking away from this SCAM with smiles.
Cash on hand will be less then 3 million at the end of this qtr. In typical Kenny fashion the numbers are made to look better then they are. 4.5 million on hand 8/31/20 300k a month in normal expense brings it to 3.9 million end of qtr. Then the 1.2 million in current liabilities brings it to 2.7 million beginning of Nov. So with just the avg 900k spend per qtr doing nothing they will have 3 qtr's of cash left with 2.5 Billion shares already.
1.2 Pennies, 2.5 Billion shares, 20 year old tech no one wanted and has no patent protection anyway and only 3 qtr's worth of funding on hand that will only cover salaries. These are real numbers not made up ones.
PMCB is stuck in the darkest hour forever. LMAO
$.20 on IND Announcement!
The darkest hour is just before dawn...
LOL.
With PMCB the darkest hour is every hour.
Cash on hand will be less then 3 million at the end of this qtr. In typical Kenny fashion the numbers are made to look better then they are. 4.5 million on hand 8/31/20 300k a month in normal expense brings it to 3.9 million end of qtr. Then the 1.2 million in current liabilities brings it to 2.7 million beginning of Nov. So with just the avg 900k spend per qtr doing nothing they will have 3 qtr's of cash left with 2.5 Billion shares already.
A real Biotech would get approval for an IND and then sell shares on the news. PMCB sells a Billion Shares prior to filing and at the lowest PPS in their history. Now maxed out once again the question is did PMCB sell before filing because they know IND will be rejected and the $ 5 Million on hand will fund Kenny and Pals pay for 12-18 months? I think most who know this company know the answer.....
I knew the day wouldn't pass without the "Some entity with a lot of means wants to squash this because they have too much to loose" statement.
Its so foolish to look at the hundreds and hundreds of biotech's developing treatments for every cancer known to man and think that PMCB is the one that some entity is trying to squash. PMCB the "Biotech" run by a 75 year old Lawyer and his CPA Friend with no clinical or preclinical data in 8+ years is the company Big Pharma is worried about. Yet every week there are Multi-million dollar partnerships and buyouts happening between several pre-commercial Biotech's.